Phibro Animal Health Co. (NASDAQ:PAHC – Free Report) – Stock analysts at Zacks Research raised their Q3 2025 earnings per share estimates for shares of Phibro Animal Health in a research note issued to investors on Wednesday, February 19th. Zacks Research analyst R. Department now forecasts that the company will post earnings of $0.48 per share for the quarter, up from their prior forecast of $0.35. The consensus estimate for Phibro Animal Health’s current full-year earnings is $1.95 per share. Zacks Research also issued estimates for Phibro Animal Health’s FY2025 earnings at $1.87 EPS, Q3 2026 earnings at $0.49 EPS and Q1 2027 earnings at $0.47 EPS.
A number of other brokerages also recently issued reports on PAHC. Morgan Stanley upped their price target on Phibro Animal Health from $20.00 to $25.00 and gave the company an “equal weight” rating in a report on Tuesday, December 17th. Barclays upped their price objective on Phibro Animal Health from $20.00 to $22.00 and gave the stock an “underweight” rating in a research note on Monday, February 10th. Finally, StockNews.com cut shares of Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a research note on Thursday, February 6th. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating and one has given a buy rating to the stock. According to MarketBeat.com, Phibro Animal Health currently has an average rating of “Hold” and a consensus target price of $21.00.
Phibro Animal Health Stock Performance
Shares of Phibro Animal Health stock opened at $22.10 on Monday. The firm’s 50-day moving average is $22.20 and its 200 day moving average is $22.21. Phibro Animal Health has a 1 year low of $11.98 and a 1 year high of $26.55. The company has a debt-to-equity ratio of 2.99, a current ratio of 3.20 and a quick ratio of 1.37. The stock has a market cap of $895.12 million, a price-to-earnings ratio of 46.04, a PEG ratio of 0.45 and a beta of 0.52.
Phibro Animal Health (NASDAQ:PAHC – Get Free Report) last issued its quarterly earnings results on Wednesday, February 5th. The company reported $0.54 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.40 by $0.14. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%.
Hedge Funds Weigh In On Phibro Animal Health
Hedge funds have recently made changes to their positions in the company. Sterling Capital Management LLC boosted its position in Phibro Animal Health by 2.4% in the fourth quarter. Sterling Capital Management LLC now owns 18,762 shares of the company’s stock valued at $394,000 after buying an additional 448 shares during the last quarter. Rhumbline Advisers raised its stake in shares of Phibro Animal Health by 0.6% during the 4th quarter. Rhumbline Advisers now owns 76,582 shares of the company’s stock worth $1,608,000 after buying an additional 484 shares during the period. Los Angeles Capital Management LLC raised its position in Phibro Animal Health by 2.1% during the fourth quarter. Los Angeles Capital Management LLC now owns 24,042 shares of the company’s stock worth $505,000 after acquiring an additional 503 shares during the period. BNP Paribas Financial Markets lifted its stake in Phibro Animal Health by 3.1% in the 3rd quarter. BNP Paribas Financial Markets now owns 24,336 shares of the company’s stock valued at $548,000 after buying an additional 729 shares in the last quarter. Finally, New York State Teachers Retirement System lifted its position in shares of Phibro Animal Health by 16.7% in the fourth quarter. New York State Teachers Retirement System now owns 5,428 shares of the company’s stock valued at $114,000 after acquiring an additional 775 shares in the last quarter. 99.34% of the stock is owned by institutional investors and hedge funds.
Phibro Animal Health Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Wednesday, March 5th will be given a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a yield of 2.17%. The ex-dividend date is Wednesday, March 5th. Phibro Animal Health’s dividend payout ratio is presently 100.00%.
Phibro Animal Health Company Profile
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.
Recommended Stories
- Five stocks we like better than Phibro Animal Health
- How to Invest in Biotech Stocks
- Nebius Slides Post-Earnings: A Long-Term Buy Opportunity?
- What is a Bond Market Holiday? How to Invest and Trade
- NVIDIA Stock: A Market Barometer in Tech’s Turbulent Times
- Investing in Commodities: What Are They? How to Invest in Them
- Palantir Stock Nears Bear Market Territory – Why and What’s Next?
Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.